Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Pollyanna Álvaro, Spósito"'
Autor:
Danilo Júnior Teixeira Severino, Bruna Soares de Souza Lima Rodrigues, Pollyanna Álvaro Spósito
Publikováno v:
STUDIES IN HEALTH SCIENCES. 3:1284-1297
O Agente Comunitário de Saúde (ACS) é um profissional importante que atua nos domicílios em conjunto com a comunidade, promovendo ações de prevenção de doenças e promoção da saúde. Porém esse profissional tem sido cada vez mais acometido
Autor:
Álvaro Fernando da Silva do Nascimento, Maria Terezinha Bahia, Pollyanna Álvaro Spósito, Karolina R. Gonçalves, Isabela Ribeiro, Lívia de Figueiredo Diniz, Vanessa Carla Furtado Mosqueira, Ana Lia Mazzeti, George Luiz Lins Machado-Coelho
Publikováno v:
Biochemical Pharmacology. 148:213-221
Benznidazole and nifurtimox-treatments regimens currently used in human are supported by very limited experimental data. This study was designed to evaluate the time and dose dependence for efficacy of the most important nitroheterocyclic drugs in us
Autor:
Maria Terezinha Bahia, Priscila Fagundes Mendes, Vanessa Carla Furtado Mosqueira, Ana Lia Mazzeti, Pollyanna Álvaro Spósito, Julio A. Urbina, Kelly Christyne Miranda Pereira de Castro
Publikováno v:
Experimental Parasitology. 228:108142
We investigated the in vitro activity and selectivity, and in vivo efficacy of ravuconazole (RAV) in self-nanoemulsifying delivery system (SNEDDS) against Trypanosoma cruzi. Novel formulations of this poorly soluble C14-α-demethylase inhibitor may i
Autor:
Maria Terezinha Bahia, Gwenaelle Pound-Lana, Julio A. Urbina, Caroline de Oliveira Faria, Pollyanna Álvaro Spósito, Ana Lia Mazzeti, Vanessa Carla Furtado Mosqueira
Publikováno v:
International Journal of Nanomedicine. 12:3785-3799
Self-emulsifying drug delivery systems (SEDDSs) are lipid-based anhydrous formulations composed of an isotropic mixture of oil, surfactant, and cosurfactants usually presented in gelatin capsules. Ravuconazole (Biopharmaceutics Classification System
Autor:
Lorena Ulhôa Araújo, Kemile Toledo de Albuquerque, Kelly Cristina Kato, Gleiciely Santos Silveira, Náira Rezende Maciel, Pollyanna Álvaro Spósito, Neila Márcia Silva Barcellos, Jacqueline de Souza, Márcia Bueno, Sílvia Storpirtis
Publikováno v:
Revista Panamericana de Salud Pública, Vol 28, Iss 6, Pp 480-492 (2010)
A política de medicamentos genéricos foi implantada no Brasil em 1999 com o objetivo de estimular a concorrência comercial, melhorar a qualidade dos medicamentos e facilitar o acesso da população ao tratamento medicamentoso. O processo de implem
Autor:
Kelly Cristina Kato, Neila Márcia Silva Barcellos, Pollyanna Álvaro Spósito, Náira Rezende Maciel, Silvia Storpirtis, Márcia Martini Bueno, Kemile Toledo de Albuquerque, Lorena Ulhôa Araújo, Gleiciely Santos Silveira, Jacqueline de Souza
Publikováno v:
Repositório Institucional da UFOP
Universidade Federal de Ouro Preto (UFOP)
instacron:UFOP
Universidade Federal de Ouro Preto (UFOP)
instacron:UFOP
The Brazilian generic drugs policy was implemented in 1999 with the aim of stimulating competition in the market, improve the quality of drugs and improve the access of the population to drug treatment. The process of implementing this policy allowed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e12457e53a4adbbf7992fc945abfc7f
http://www.repositorio.ufop.br/handle/123456789/5809
http://www.repositorio.ufop.br/handle/123456789/5809
Autor:
Lorena Ulhôa, Araújo, Kemile Toledo de, Albuquerque, Kelly Cristina, Kato, Gleiciely Santos, Silveira, Náira Rezende, Maciel, Pollyanna Álvaro, Spósito, Neila Márcia Silva, Barcellos, Jacqueline de, Souza, Márcia, Bueno, Sílvia, Storpirtis
Publikováno v:
Revista panamericana de salud publica = Pan American journal of public health. 28(6)
The Brazilian generic drugs policy was implemented in 1999 with the aim of stimulating competition in the market, improve the quality of drugs and improve the access of the population to drug treatment. The process of implementing this policy allowed